Not Rated
|
Fund Size
(0.64% of Investment in Category)
|
Expense Ratio
(0.89% Category average)
|
| Period Invested for | ₹10000 Invested on | Latest Value | Absolute Returns | Annualised Returns | Category Avg | Rank within Category |
|---|---|---|---|---|---|---|
| 1 Week | 18-Nov-25 | 10404.50 | 4.04% | - | 0.02% | 2/230 |
| 1 Month | 24-Oct-25 | 10230.60 | 2.31% | - | 0.68% | 40/229 |
| 3 Month | 25-Aug-25 | 10497.20 | 4.97% | - | 4.25% | 90/227 |
| 6 Month | 23-May-25 | 11904.10 | 19.04% | - | 6.38% | 4/216 |
| YTD | 31-Dec-24 | 11385.70 | 13.86% | - | 5.81% | 35/202 |
| 1 Year | 25-Nov-24 | 10995.70 | 9.96% | 9.96% | 6.26% | 44/188 |
| 2 Year | 24-Nov-23 | 13811.40 | 38.11% | 17.47% | 19.41% | 98/145 |
| 3 Year | 25-Nov-22 | 16250.30 | 62.50% | 17.55% | 19.95% | 78/118 |
| 5 Year | 25-Nov-20 | 19622.30 | 96.22% | 14.42% | 21.47% | 85/94 |
| 10 Year | 24-Nov-15 | 42134.50 | 321.34% | 15.45% | 15.51% | 35/66 |
| Since Inception | 02-Jan-13 | 71847.10 | 618.47% | 16.51% | 14.27% | 107/223 |
| Period Invested for | ₹1000 SIP Started on | Investments | Latest Value | Absolute Returns | Annualised Returns |
|---|---|---|---|---|---|
| 1 Year | 25-Nov-24 | 12000 | 13337.98 | 11.15 % | 21.2 % |
| 2 Year | 24-Nov-23 | 24000 | 28075.36 | 16.98 % | 15.84 % |
| 3 Year | 25-Nov-22 | 36000 | 46073.18 | 27.98 % | 16.67 % |
| 5 Year | 25-Nov-20 | 60000 | 86936.83 | 44.89 % | 14.8 % |
| 10 Year | 24-Nov-15 | 120000 | 278743.78 | 132.29 % | 16.07 % |
If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 12.5%, if your total long term capital gain exceeds 1.25 lakh. Any cess/surcharge is not included. If sold before 1 year from purchase date, short term capital gain tax will be applicable. Current tax rate is 20%. Any cess/surcharge is not included in the 20%.
Top 10 Stocks in Portfolio
| Stock Invested in | Sector | Value(Mn) | % of Total Holdings | 1M Change | 1Y Highest Holding | 1Y Lowest Holding | Quantity | 1M Change in Qty |
|---|---|---|---|---|---|---|---|---|
| # Huntington Ingalls Industries Inc | Foreign equity | 1087.6 | 3.20% | 0.00% | 3.64% (Apr 2025) | 0% (Nov 2024) | 38.07 k | -0.61 k |
| # Alphabet Inc - Class C | Foreign equity | 1032.1 | 3.04% | 0.00% | 2.97% (Sep 2025) | 0% (Nov 2024) | 41.28 k | -4.70 k |
| # Estee Lauder CL | Foreign equity | 989.7 | 2.91% | 0.00% | 2.89% (Jul 2025) | 0% (Nov 2024) | 1.15 L | 0.00 |
| # Agilent Technologies Inc | Foreign equity | 983.4 | 2.90% | 0.00% | 2.58% (Sep 2025) | 0% (Nov 2024) | 75.73 k | 0.00 |
| # West Pharmaceutical Services Inc | Foreign equity | 929.4 | 2.74% | 0.00% | 2.98% (Mar 2025) | 0% (Nov 2024) | 37.14 k | -3.50 k |
| # Thermo Fisher Scientific Inc | Foreign equity | 892 | 2.63% | 0.00% | 2.28% (Sep 2025) | 0% (Nov 2024) | 17.72 k | 0.00 |
| # Zimmer Biomet Holdings Inc. | Foreign equity | 838.7 | 2.47% | 0.00% | 2.73% (Mar 2025) | 0% (Nov 2024) | 94.00 k | 0.00 |
| # Bristol Myers Squibb Co | Foreign equity | 829.2 | 2.44% | 0.00% | 2.8% (Feb 2025) | 0% (Nov 2024) | 2.03 L | 21.00 k |
| # US Bancorp | Foreign equity | 803.6 | 2.37% | 0.00% | 2.61% (Nov 2024) | 0% (Nov 2024) | 1.94 L | 0.00 |
| # Merck & Co Inc Shs | Foreign equity | 803.3 | 2.37% | 0.00% | 2.35% (Sep 2025) | 0% (Nov 2024) | 1.05 L | 0.00 |
| Name | Type of Instrument | Weight (%) |
|---|---|---|
| Net Receivables | Net Receivables | 2.37% |
| TREPS | TREPS | 0.22% |
Ratios calculated on daily returns for last 3 years (Updated as on 31st October, 2025)
Out of 108 mutual fund schemes offered by this AMC, 6 is/are ranked 5 * , 8 is/are ranked 4 * , 9 is/are ranked 3 * , 5 is/are ranked 2 * , 3 is/are ranked 1 * , and 77 schemes are not ranked. See more about AMC